| Literature DB >> 16690522 |
Bassem T Chaar1, Pascale Salem, Paul J Petruska.
Abstract
Procarbazine hydrochloride is an oral alkylating agent with activity against lymphoma. It is most commonly used in the treatment of Hodgkin's disease. The use of procarbazine-containing chemotherapeutic regimens in non-Hodgkin's lymphoma fell out of favor with the advent of CHOP. We report two patients with relapsed and/or refractory follicular lymphoma that achieved a complete and durable remission with a prolonged course of daily procarbazine.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16690522 DOI: 10.1080/10428190600591517
Source DB: PubMed Journal: Leuk Lymphoma ISSN: 1026-8022